ONCOSEC MED INC's ticker is ONCS and the CUSIP is 68234L306. A total of 33 filers reported holding ONCOSEC MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | -80.0% | 16,000 | -69.5% | 0.00% | -100.0% |
| Q1 2022 | $60,000 | +9.1% | 52,500 | -8.7% | 0.00% | 0.0% |
| Q4 2021 | $55,000 | -76.2% | 57,500 | -47.0% | 0.00% | -66.7% |
| Q3 2021 | $231,000 | -29.1% | 108,500 | -6.4% | 0.00% | -25.0% |
| Q2 2021 | $326,000 | -41.6% | 115,900 | -0.9% | 0.00% | -42.9% |
| Q1 2021 | $558,000 | -26.7% | 117,000 | -0.8% | 0.01% | -41.7% |
| Q4 2020 | $761,000 | +89.3% | 118,000 | -0.8% | 0.01% | +71.4% |
| Q3 2020 | $402,000 | +65.4% | 119,000 | +0.4% | 0.01% | +40.0% |
| Q2 2020 | $243,000 | +182.6% | 118,500 | +74.9% | 0.01% | +150.0% |
| Q1 2020 | $86,000 | -30.1% | 67,750 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $123,000 | +161.7% | 67,750 | +182.3% | 0.00% | +100.0% |
| Q3 2019 | $47,000 | – | 24,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SALZHAUER MICHAEL | 277,312 | $591,000 | 0.24% |
| Avidity Partners Management LP | 2,945,000 | $6,273,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 316,229 | $674,000 | 0.12% |
| J. Goldman & Co LP | 790,242 | $1,683,000 | 0.08% |
| Sandbox Financial Partners, LLC | 25,000 | $53,000 | 0.04% |
| Virtu Financial LLC | 25,166 | $54,000 | 0.01% |
| D.A. DAVIDSON & CO. | 108,500 | $231,000 | 0.00% |
| J. Goldman & Co LP | 26,300 | $56,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 361,401 | $770,000 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 49,500 | $105,000 | 0.00% |